First‐Tier Versus Last‐Tier Trio Whole‐Genome Sequencing for the Diagnosis of Pediatric‐Onset Rare Diseases
Clinical Genetics · 2025
DOI: 10.1111/cge.14760 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2025. Verfasst von Camilla Lucca und 26 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Genetics, ASST Papa Giovanni XXIII, Bergamo, Italy. Hauptthemen laut MEDLINE: Whole Genome Sequencing, Rare Diseases, Genetic Testing. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Plan for NRRP Complementary Investments (PNC, established with the decree-law 6 May 2021, n. 59, converted by law n. 101 of 2021) in the call for the…, "PG23/FROM 2017 Call for Independent Research" as part of the RARE - Rapid Analysis for Rapid carE - project, Illumina Inc.
Abstract (Originalsprache)
Despite advances in diagnostics, children with rare genetic disorders still face extended diagnostic odysseys, delaying appropriate clinical management, and placing burdens on families and healthcare resources. Whole‐genome sequencing (WGS) offers a more comprehensive interrogation of the genome than other genetic tests, but its use in clinical practice remains limited. This study compared diagnostic rates, turnaround times, and clinical utility of first‐tier versus last‐tier trio‐WGS for patients with suspected genetic pediatric‐onset conditions, including 97 critical and 104 non‐critical patients. Eighty‐five patients (42.3%), including 57 (58.8%) critical and 28 (26.9%) non‐critical patients, received a molecular diagnosis. The diagnostic rate was higher for first‐tier (57%) than for last‐tier (32.8%) trio‐WGS. Of 121 causative variants identified, 19.8% would have been missed by whole‐exome sequencing. Laboratory processing time was 4 days for all patients. The clinical setting had the greatest impact on time to reporting, averaging 5 days for critical patients versus 74 days for outpatients. WGS results impacted clinical decision‐making for 34% of all critical and 14.3% of WGS‐positive non‐critical patients. This is the first Italian clinical study to demonstrate the diagnostic and clinical utility of a genome‐first approach for both critical and non‐critical patients with suspected genetic pediatric‐onset disorders and feasibility in a public healthcare system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Medical Genetics, ASST Papa Giovanni XXIII, Bergamo, Italy.
- Fondazione IRCCS ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Rare Disease Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
- Medical Affairs Europe, Illumina, Inc., Cambridge, UK.
- Clinical Genetics Unit, Department of Obstetrics and Gynecology, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.
- Inherited Metabolic Disorders Unit Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
ORCID-Profile: Donatella Milani, Maria Francesca Bedeschi
Förderung
- National Plan for NRRP Complementary Investments (PNC, established with the decree-law 6 May 2021, n. 59, converted by law n. 101 of 2021) in the call for the…
- "PG23/FROM 2017 Call for Independent Research" as part of the RARE - Rapid Analysis for Rapid carE - project
- Illumina Inc
- Telethon Foundation
- Fondazione Telethon
Zitieren
APA
Lucca, C., Rosina, E., Pezzani, L., Piazzolla, D., Spaccini, L., Scatigno, A., Gasperini, S., Pezzoli, L., Cereda, A., Milani, D., Cattaneo, E., Cavallari, U., Frigeni, M., Marchetti, D., Daolio, C., Giordano, L., Bellini, M., Goisis, L., Mongodi, C., …, & Iascone, M. (2025). First‐Tier Versus Last‐Tier Trio Whole‐Genome Sequencing for the Diagnosis of Pediatric‐Onset Rare Diseases. Clinical Genetics. https://doi.org/10.1111/cge.14760
Vancouver
Lucca C, Rosina E, Pezzani L, Piazzolla D, Spaccini L, Scatigno A, et al. First‐Tier Versus Last‐Tier Trio Whole‐Genome Sequencing for the Diagnosis of Pediatric‐Onset Rare Diseases. Clinical Genetics. 2025. doi:10.1111/cge.14760
BibTeX
@article{Lucca2025,
author = {Lucca, Camilla and Rosina, Erica and Pezzani, Lidia and Piazzolla, Daniela and Spaccini, Luigina and Scatigno, Agnese and Gasperini, Serena and Pezzoli, Laura and Cereda, Anna and Milani, Donatella and Cattaneo, Elisa and Cavallari, Ugo and Frigeni, Marco and Marchetti, Daniela and Daolio, Cecilia and Giordano, Laura and Bellini, Matteo and Goisis, Lucrezia and Mongodi, Chiara and Tonduti, Davide and Pilotta, Alba and Cazzaniga, Giovanni and Furlan, Francesca and Bedeschi, Maria Francesca and Mangili, Giovanna and Bonanomi, Ezio and Iascone, Maria},
title = {First‐Tier Versus Last‐Tier Trio Whole‐Genome Sequencing for the Diagnosis of Pediatric‐Onset Rare Diseases},
journal = {Clinical Genetics},
year = {2025},
doi = {10.1111/cge.14760}
}
EUVIMED